colforsin has been researched along with Adenocarcinoma Of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brinkley, G; Buckhaults, P; Chandrashekar, DS; Karki, S; Kirkman, R; Kundu, A; Livi, CB; Mitchell, T; Nam, H; Rowe, GC; Shelar, S; Sudarshan, S; Tang, Y; Varambally, S; Wei, S | 1 |
| Göhring, B; Kehlen, A; Langner, J; Riemann, D | 1 |
2 other study(ies) available for colforsin and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
PRDM16 suppresses HIF-targeted gene expression in kidney cancer.
Topics: Alcohol Oxidoreductases; Animals; Carcinoma, Renal Cell; Cell Movement; Cell Proliferation; Colforsin; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Neoplasms; Membrane Glycoproteins; Mice; Mitochondria; Models, Biological; Phenotype; Promoter Regions, Genetic; Rosiglitazone; Semaphorins; Transcription Factors; Transcription, Genetic; Wound Healing; Xenograft Model Antitumor Assays | 2020 |
Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.
Topics: Adjuvants, Immunologic; Aminopeptidases; Calcimycin; Carcinoma, Renal Cell; CD13 Antigens; Cholera Toxin; Colforsin; Cyclic AMP; Cytokines; Dinoprostone; Dipeptidyl Peptidase 4; Epithelial Cells; Glutamyl Aminopeptidase; Humans; Ionophores; Kidney Neoplasms; Kidney Tubules; Leucine; Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic | 1998 |